论文部分内容阅读
Purpose: To evaluate the additive effects of carteolol, a nonse-lective beta-blocker, and nipradilol, a newly developed alpha/beta- blocker, when used with latanoprost to lower the intraocular pressure (IOP) in glaucoma patients. Design: Open label randomized clinical study. Methods: Fifty-seven patients (57
Purpose: To evaluate the additive effects of carteolol, a nonse-lective beta-blocker, and nipradilol, a newly developed alpha / beta-blocker, when used with latanoprost to lower the intraocular pressure (IOP) in glaucoma patients. randomized clinical study. Methods: Fifty-seven patients (57